Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs
Open accessThe DOI matches its Crossref record; 224 of the 231 references it cites were found in a registry or an index.
Abstract
ATP-binding cassette (ABC) transporters are transmembrane proteins expressed commonly in metabolic and excretory organs to control xenobiotic or endobiotic disposition and maintain their homeostasis. Changes in ABC transporter expression may directly affect the pharmacokinetics of relevant drugs involving absorption, distribution, metabolism, and excretion (ADME) processes. Indeed, overexpression of efflux ABC transporters in cancer cells or bacteria limits drug exposure and causes therapeutic failure that is known as multidrug resistance (MDR). With the discovery of functional noncoding microRNAs (miRNAs) produced from the genome, many miRNAs have been revealed to govern posttranscriptional gene regulation of ABC transporters, which shall improve our understanding of complex mechanism behind the overexpression of ABC transporters linked to MDR. In this article, we first overview the expression and localization of important ABC transporters in human tissues and their clinical importance regarding ADME as well as MDR. Further, we summarize miRNA-controlled posttranscriptional gene regulation of ABC transporters and effects on ADME and MDR. Additionally, we discuss the development and utilization of novel bioengineered miRNA agents to modulate ABC transporter gene expression and subsequent influence on cellular drug accumulation and chemosensitivity. Findings on posttranscriptional gene regulation of ABC transporters shall not only improve our understanding of mechanisms behind variable ADME but also provide insight into developing new means towards rational and more effective pharmacotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In various cancers, including CRC, miRNAs that target ABC transporters have been reported to modulate the chemosensitivity of cancer cells [102,103].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–224 of 224
Tu, M., Duan, Z., Liu, Z., Zhang, C., Bold, R. J., Gonzalez, F. J., Kim, E. J.-H., & Yu, A. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000130 · Cited by 39
Self-citationXie, Y., Shao, Y., Deng, X., Wang, M., & Chen, Y. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00602 · Cited by 38
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
Chen, J., Wang, Z., Gao, S., Wu, K., Bai, F., Zhang, Q., Wang, H., Ye, Q., Xu, F., Sun, H., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01842-x · Cited by 38
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
Han, K., Kahng, J., Kim, M., Lim, J., Kim, Y., Cho, B., Kim, H. K., Min, W. S., Kim, C. C., Lee, K. Y., et al. (2000) · Acta Haematologica · doi:10.1159/000046511 · Cited by 37
Li, M.-M., Wang, W.-P., Wu, W.-J., Huang, M., & Yu, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060145 · Cited by 37
Self-citationCytochrome P450 humanised mice
Gonzalez, F. J. (2004) · Human Genomics · doi:10.1186/1479-7364-1-4-300 · Cited by 36
Li, P.-C., Tu, M., Ho, P. Y., Batra, N., Tran, M., Qiu, J.-X., Wun, T., Lara, P. N., Hu, X., Yu, A.-X., et al. (2021) · Theranostics · doi:10.7150/thno.56596 · Cited by 35
Self-citationLi, Y., Gong, P., Hou, J., Huang, W. Q., Ma, X., Wang, Y., Li, J., Cui, X., & Li, N. (2018) · Journal of Immunology Research · doi:10.1155/2018/7498514 · Cited by 34
Self-citationMicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
Kaehler, M., Ruemenapp, J., Gonnermann, D., Nagel, I., Bruhn, O., Haenisch, S., Ammerpohl, O., Wesch, D., Cascorbi, I., & Bruckmueller, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21272 · Cited by 33
Jilek, J. L., Tu, M., Zhang, C., & Yu, A. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000207 · Cited by 30
Self-citationXie, Z., Wang, F., Xiao, Z., Liu, S., Tang, S., & Lai, Y. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa012 · Cited by 27
Deng, L., Petrek, H. E., Tu, M., Batra, N., Yu, A., & Yu, A. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.027 · Cited by 25
Self-citationInsight on Multidrug Resistance and Nanomedicine Approaches to Overcome MDR
Mohammad, I. S., He, W., & Yin, L. (2020) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2020025052 · Cited by 25
Meyers, M. B., Scotto, K. W., & Sirotnak, F. M. (1991) · Cancer Communications · doi:10.3727/095535491820873335 · Cited by 25
Ning, S., Liu, C., Lou, W., Yang, J. C., Lombard, A. P., D'Abronzo, L. S., Batra, N., Yu, A., Leslie, A. R., Sharifi, M., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0216 · Cited by 23
Self-citationHrycyna, C. A., & Gottesman, M. M. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80019-8 · Cited by 20
Koehn, L. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_76-1 · Cited by 18
Gromnicova, R., Romero, I. A., & Male, D. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048189 · Cited by 17
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer
Chen, Y., Tu, M., Han, F., Liu, Z., Batra, N., Lara, P. N., Chen, H.-W., Bi, H., & Yu, A. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.011 · Cited by 15
Self-citationCronin, J. M., & Yu, A. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001008 · Cited by 14
Self-citationLaddha, A. P., Dzielak, L., Lewis, C., Xue, R., & Manautou, J. E. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167037 · Cited by 14
Expression and Purification of tRNA/pre-miRNA-Based Recombinant Noncoding RNAs
Tu, M., Wright, H. K., Batra, N., & Yu, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1499-0_18 · Cited by 14
Self-citationNovel RNA molecular bioengineering technology efficiently produces functional miRNA agents
Traber, G. M., Yi, C., Batra, N., Tu, M., & Yu, A. (2024) · RNA · doi:10.1261/rna.079904.123 · Cited by 11
Self-citationGalluccio, M., Scalise, M., Pappacoda, G., Scarpelli, M., Bonanomi, M., Gaglio, D., & Indiveri, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.993626 · Cited by 7
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“In various cancers, including CRC, miRNAs that target ABC transporters have been reported to modulate the chemosensitivity of cancer cells [102,103].”
Multidimensional tumor heterogeneity and its role in therapeutic resistance
Mubin, N., Alnukhali, M., Ahmad, N., Driscoll, J. J., & Ahmad, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1794130 · Cited by 24
Arunrat, N., Mhuantong, W., & Sereenonchai, S. (2025) · Microbial Ecology · doi:10.1007/s00248-025-02598-x · Cited by 13
The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage
Călin, G. A., Hubé, F., Ladomery, M., Delihas, N., Ferracin, M., Poliseno, L., Agnelli, L., Alahari, S. K., Yu, A., & Zhong, X. (2024) · Non-Coding RNA · doi:10.3390/ncrna10060062 · Cited by 16
Self-citationSmall RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions
Cronin, J. M., & Yu, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1720361 · Cited by 17
Self-citation
Metadata
- Authors
- Wang, Y., Tu, M.-J., & Yu, A.-M.
- Affiliations
- University of California, Davis (US)
- Corresponding author
- Yu, Ai-Ming
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2024-07-24
- Volume
- 15
- Pages
- 1423416-1423416
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC11303158
- OpenAlex
- W4400963431
- Cited by
- 21
- References
- 231
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA253230, R01CA225958, P30CA093373)
- National Institute of General Medical Sciences (R35GM140835)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- ABC transporters, drug efflux, microRNA, post-transcriptional regulation, multidrug resistance, drug disposition, pharmacokinetics, ADME, xenobiotic metabolism, chemosensitivity, drug accumulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.